Author:
Hendrix Suzanne B.,Nicodemus-Johnson Jessie,Kowallis Logan,Knowlton Newman,Hennessey Sean,Dickson Samuel P.
Publisher
Cambridge University Press
Reference24 articles.
1. 24. European Medicines Agency. Clinical investigation of medicines for the treatment of Alzheimer’s disease/ CPMP/EWP/553/1995. Available at: www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicines-treatment-alzheimers-disease-revision-2_en.pdf (accessed January 20, 2021).
2. Group sequential clinical trials with triangular continuation regions;Whitehead;Biometrics,1983
3. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease;Kivipelto;Nat Rev Neurol,2018
4. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study;Ismail;J Neuroinflammation,2020
5. Using global statistical tests in long-term Parkinson’s disease clinical trials;Huang;Mov Disord,2009